Dr. Steven Burakoff is the Director of The Tisch Cancer Institute at Mount Sinai Hospital in New York City. At the Icahn School of Medicine at Mount Sinai, he is Lillian and Henry M. Stratton Professor of Cancer Medicine; Professor of Medicine, Hematology and Medical Oncology; and Professor, Oncological Sciences.
Dr. Burakoff is a renowned physician whose substantial academic research efforts have focused on understanding and modulating the immune system. His principal research interests are in cellular and molecular immunology, transplantation immunology and T cell activation and signal transduction. Dr. Burakoff has held consulting appointments with several of the world’s leading pharmaceutical companies, including Novartis, Hoffman-la Roche and Bristol Myers-Squibb. He has received numerous professional awards, including the Lifetime Achievement Award from the American Association of Immunologists.
Before joining Mount Sinai, Dr. Burakoff was Director, New York University Cancer Institute and Kaplan Comprehensive Cancer Center and then Director of the Skirball Institute of Biomolecular Medicine, New York University School of Medicine. Previously, he was Chair of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute.
Dr. Burakoff has published more than 300 peer-reviewed articles (click here) on various medical topics.
Dr. Burakoff received a B.A. with honors from Lehigh University and a M.A. (in Psychology) from Queens College. He obtained his medical degree from Albany Medical College. He completed his residency in general medicine at Cornell Medical Center and a fellowship in immunology at Rockefeller University.
Watch Dr. Burakoff’s presentation at the 2014 National CyTOF Meeting.